GCB Newsletter Volume 3: Fall 2018

artistic rendering of a strand of DNA
GCB News

GCB Newsletter Volume 3: Fall 2018

Highlights to the current issue include:

  • Targeted epigenome editing as 'next generation drugs' for Parkinson's disease
  • New Genomic Medicine Collaboratory to serve as nexus for genetics, genomics community
  • Element Genomics acquired by global pharmaceuticals company
  • New Funding
  • Chris Nelson earns K99 grant
  • New undergrad course offers comprehensive overview of genome science tech
  • Tagliafierro receives grant to examine associations between aging, genetics, and Alzheimer's disease
  • Inaugural Summer Scholars Program Wrap Ups in End-of-Summer Poster Session
  • New GCB Collaboration Brings German Researchers, Scholars Stateside
  • Updates from the Cores
  • 2018 Fall SOM Core Facility Voucher Program

Read more

Related News

two babboons fighting

Baboon Sexes Differ in How Social Status Gets 'Under the Skin'

A growing body of evidence shows that those at the bottom of the socioeconomic ladder are more likely to die prematurely than those at the top.
view
Charlie Gersbach, Ph.D.

Gersbach awarded gene therapy research grant from Gilbert Family Foundation

The Gilbert Family Foundation announced its first major initiative around gene therapy research.
view
Terrie Moffit, Ph.D.

Terrie Moffitt Earns 'Juvenile Justice Without Borders' International Award

Life-course research includes criminality and anti-social behavior
view